Announcement under SEBI Listing Regulation regarding schedule of Institutional investor meet.

Date: October 27, 2026 Ref:- GHL/2026-27/EXCH/ 67 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, P J Towers, Dalal Street, National Stock Exchange of India Limited Mumbai - 400 001, India. Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051, India. Scrip Code: 543654 Symbol: MEDANTA Sub: Intimation for Earnings Conference Call under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Earnings Conference Call has been scheduled for Wednesday, November 04, 2026 at 02:00 P.M (IST). The call will be hosted by Investec Capital Services (India) Private Limited for Second Quarter and Half Year ended September 30, 2026 financial results. The details of Earnings Conference call is enclosed herewith and is also available on the website of the Company at https://www.medanta.org/ Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Kindly take the above on record. For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M.No. A17035 Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 Global Health Limited Q2 FY2027 Earnings Conference Call Wednesday, 4th November, 2026 at 2:00 PM IST 3:30 AM USA EST | 8:30 AM UK Time | 4:30 PM HK/Singapore Time Global Health Limited (Medanta): The management of the company is pleased to invite you to the Q2 FY2027 results conference call hosted by Investec Capital on Wednesday, 4th November, 2026 at 2:00 PM. The management team will be represented by: Dr. Naresh Trehan – Chairman & Managing Director Mr. Pankaj Sahni – Group CEO & Director Mr. Yogesh Kumar Gupta – Chief Financial Officer Mr. Gaurav Chugh – Head Investor Relations Details of the conference call are as under: Date and Time: 4th November, 2026 (Wednesday) at 2:00 PM IST Universal Dial In: +91-22-7195 0000 Toll Free Numbers - International Singapore: 800 101 1997 Hong Kong: 800 900 919 USA: 1 877 271 3944 UK: 0 808 101 1132 Please register in advance using the link given below; most convenient method to connect with zero wait time: For further information, please contact: Investec Capital Services (India) Private Ltd Anshuman Gupta: +91 96191 78067 Anshuman.Gupta@investec.com Global Health Limited Gaurav Chugh - Head Investor Relations Bhushan Khandelwal - Investor Relations Investor.relations@medanta.org About Medanta: Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest civilian awards in India, and the Dr. B.C. Roy Award in recognition of his distinguished contribution to medicine. Global Health Limited (the “Company”) is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, with key specialties cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology, according to the report titled “An assessment of the healthcare delivery market in India, September 2022” by CRISIL Limited. Under the “Medanta” brand, the Company has a network of six hospitals currently in operation (Gurgaon, Indore, Ranchi, Lucknow, Patna and Noida). Spanning an area of 5.6 million sq.ft., its operational hospitals have 3,737 installed beds as on June 30, 2026, It also has seven upcoming hospitals in Mumbai, Guwahati, Varanasi and four hospitals in Delhi NCR. The Company provides healthcare services in over 30 medical specialties and engages over 2,480+ doctors led by highly experienced department heads. For more information please log onto: www.medanta.org